Mass Vaccination in a Pandemic - Benefits versus Risks: interview with Geert Vanden Bossche

First published at 18:47 UTC on March 23rd, 2021.

Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research. Interview by Philip McMillan (Vejon Health)

CategoryNone
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO